PSNPrescribable
carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Crexont Capsule, Extended Release
RxNorm Crosswalk NDC 64896-968
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Crexont (NDC 64896-968) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 8 unique RxNorm concepts. By anchoring Amneal Pharmaceuticals Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule
(RxCUI 2690259)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
CREXONT 35 MG / 140 MG Extended Release Oral Capsule
(RxCUI 2690265)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule
(RxCUI 2690279)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule
(RxCUI 2690281)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule
(RxCUI 2690284)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
CREXONT 70 MG / 280 MG Extended Release Oral Capsule
(RxCUI 2690286)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule
(RxCUI 2690290)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule
(RxCUI 2690292)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Crexont
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 64896-968 to RxCUI 2690259, 2690265, 2690279, 2690281, 2690284, 2690286, 2690290, 2690292, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
* Please review the full disclaimer at the bottom of this page.
